The measurement of the use of specialized feeding techniques by the digestive system with the aim of developing the best way of feeding patients with digestive diseases such as acute pancreatitis. Intravenous feeding is one of the greatest advances in the management of surgical and critical-care patients in modern times. It especially helps in complicated abdominal procedures promoting faster recovery and preventing malnutrition, reduced host defense, and slower healing of wounds. However, it poses some problems by not utilizing the body's natural functions and disrupts metabolic control exerted by the liver and pancreas on the inflow of nutrients into the bloodstream. In the disease of acute pancreatitis, feeding through the intestines (enteral feeding), may worsen the symptoms. So, intravenous feeding has been favored. In this study, the proposal is to compare the physiological effects of feeding through the intestines and the effects of feeding intravenously on the synthesis and secretion of pancreatic enzymes, first in healthy volunteers, and then in patients with acute pancreatitis. This will enable the design of the safest and most cost effective method of nutritional support for patients with acute pancreatitis. The study will involve healthy volunteers who will be randomly divided into four groups, each group using a different diet. Subjects will be admitted to the General Clinical Research Center at MCV. A feeding tube (NGtube) will be passed through the nose into the stomach, the stomach will be emptied with the help of a drug, a light dinner will be provided, and fasting will occur until the next morning. In the morning, an intravenous (IV) catheter will be inserted into an arm. Two different amino acids will be administered, one through the IV and one through the NG tube. During the test, half-hourly samples of digestive juice will be suctioned from the feeding tube to measure the amount of amino acids in the digestive enzymes. Blood and breath samples will be taken. At the end of the test, a tube will be passed into the stomach and intestine and intestinal lining will be taken for analysis.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR000065-38
Application #
6419267
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Project Start
1977-12-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
38
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Holkova, Beata; Yazbeck, Victor; Kmieciak, Maciej et al. (2017) A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphoma. Leuk Lymphoma 58:1349-1357
Corey, Kathleen E; Vuppalanchi, Raj; Vos, Miriam et al. (2015) Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 60:360-7
Eaton, J E; Juran, B D; Atkinson, E J et al. (2015) A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease. Aliment Pharmacol Ther 41:980-90
Worthington Jr, Everett L; Berry, Jack W; Hook, Joshua N et al. (2015) Forgiveness-reconciliation and communication-conflict-resolution interventions versus retested controls in early married couples. J Couns Psychol 62:14-27
Holkova, Beata; Kmieciak, Maciej; Perkins, E Brent et al. (2014) Phase I trial of bortezomib (PS-341; NSC 681239) and ""nonhybrid"" (bolus) infusion schedule of alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory indolent B-cell neoplasms. Clin Cancer Res 20:5652-62
Lo, D J; Farris, A B; Song, M et al. (2013) Inhibition of ?v?6 promotes acute renal allograft rejection in nonhuman primates. Am J Transplant 13:3085-93
Jones, Robert; Vuky, Jacqueline; Elliott, Tony et al. (2013) Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer. Invest New Drugs 31:1001-7
Al Hawaj, M A; Martin, E J; Venitz, J et al. (2013) Monitoring rFVIII prophylaxis dosing using global haemostasis assays. Haemophilia 19:409-14
Noureddin, Mazen; Yates, Katherine P; Vaughn, Ivana A et al. (2013) Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients. Hepatology 58:1644-54
Lo, D J; Anderson, D J; Weaver, T A et al. (2013) Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion. Am J Transplant 13:320-8

Showing the most recent 10 out of 367 publications